Facebook Twitter Youtube

05Aug

Methodist Estabrook Cancer Center Awarded FACT Accreditation

OMAHA  –  Methodist Estabrook Cancer Center (MECC) has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center.  By demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration, MECC has earned FACT Accreditation for its stem cell program. 

The accreditation was one of only three awarded to Nebraska facilities.

FACT is an internationally-recognized accrediting body for hospitals and medical institutions offering stem cell transplant, and indicates the accredited institution has met the most rigorous standards in every aspect of stem cell therapy.  This covers the entire spectrum of stem cell therapy, from clinical care to donor management, cell collection, processing, storage, transportation, administration, and cell release.

FACT-JACIE Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy transplantation. MECC has been found to be in compliance with these rigorous Standards as well as governmental regulations.

“We endeavored to achieve accreditation for our organization because FACT accreditation has evolved into an all-but-necessary qualification to be accepted and competitive in the field of cellular therapy,” said Patty Bauer, service executive at Methodist Estabrook Cancer Center.  “We believe FACT Accreditation will make patients aware that our facility strives to achieve the highest quality care for cellular therapy treatment programs.”

“We are pleased that Methodist Estabrook Cancer Center has met the requirements of the Foundation and has been granted accreditation for their stem cell program,” said Dr. Phyllis Warkentin, FACT’s Chief Medical Officer.

FACT conducted an on-site evaluation of Methodist Estabrook Cancer Center on May 14.  Accreditation is attained through evaluation of submitted documentation and on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration’s current rules for Good Tissue Practice.  FACT Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy.